Bioequivalence study of abacavir/lamivudine (600/300-mg) tablets in healthy Thai volunteers under fasting conditions
Saved in:
Main Authors: | Ekawan Yoosakul (Author), Jaturavit Vattanarongkup (Author), Chutima Manamuti (Author), Bancha Chuasuwan (Author), Isariya Techatanawat (Author), Busarat Karachot (Author), Porranee Puranajoti (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Abacavir/lamivudine combination in the treatment of HIV: a review
by: Geetha Sivasubramanian, et al.
Published: (2010) -
Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells
by: Saye H. Khoo, et al.
Published: (2011) -
Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children
by: Torsak Bunupuradah, et al.
Published: (2015) -
Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks
by: Julián Olalla, et al.
Published: (2018) -
Abacavir: it's use and hypersensitivity
by: Helena Rabie, et al.
Published: (2009)